Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 6/20 | 0.60 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.60 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.60 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.50 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | CD69 | Q07108 | 1/20 | 0.48 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.47 |
| ▸ | AMY2A | P04746 | 2/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.47 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.43 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30110520 | 1.00 | LGALS3 (0.60) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL29370786 | 1.00 | LGALS3 (0.60) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL29419069 | 1.00 | LGALS3 (0.60) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL17148009 | 1.00 | LGALS3 (0.60) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL17148015 | 1.00 | LGALS3 (0.60) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL29694256 | 0.98 | LGALS3 (0.59) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL29370195 | 0.97 | LGALS3 (0.57) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL29532287 | 0.97 | LGALS3 (0.61) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31154034 | 0.96 | LGALS3 (0.56) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL30943987 | 0.96 | LGALS3 (0.56) | LGALS3LGALS8LGALS4CD209ENGASE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731249-A1 | A RECOMBINANT HUMAN ALPHA-1 ANTITRYPSIN GLYCOPROTEIN | AATEC Medical GmbH (DE) | 2026-04-29 | — | — | EP | claimed |
| WO-2025029879-A1 | ASSESSING AND TREATING MAMMALS HAVING METABOLIC DISORDERS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2025-02-06 | — | — | WO | claimed |
| WO-2024261142-A1 | A RECOMBINANT HUMAN ALPHA-1 ANTITRYPSIN GLYCOPROTEIN | AATEC MEDICAL GMBH (DE) | 2024-12-26 | — | — | WO | claimed |
| EP-4480960-A1 | A RECOMBINANT HUMAN ALPHA-1 ANTITRYPSIN GLYCOPROTEIN | AATEC Medical GmbH (DE) | 2024-12-25 | — | — | EP | claimed |
| US-20240382560-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY | GNUBIOTICS SCIENCES SA (CH) | 2024-11-21 | — | — | US | claimed |
| EP-4401753-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY | Gnubiotics Sciences SA (CH) | 2024-07-24 | — | — | EP | claimed |
| EP-3288599-B1 | WOUND PACKING MATERIAL COMPRISING CHEMOEFFECTOR | CHEMOKIND INC (US) | 2023-06-07 | — | — | EP | claimed |
| WO-2023041979-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY | GNUBIOTICS SCIENCES SA (CH) | 2023-03-23 | — | — | WO | claimed |
| EP-4731249-A1 | A RECOMBINANT HUMAN ALPHA-1 ANTITRYPSIN GLYCOPROTEIN | AATEC Medical GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4730999-A1 | RECOMBINANT AAT FROM YEAST TO TREAT TRANSPLANTS | AATEC Medical GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4731251-A1 | RECOMBINANT AAT FROM YEAST TO TREAT BACTERIAL RESPIRATORY INFECTIONS | AATEC Medical GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4731250-A1 | A RECOMBINANT HUMAN ALPHA-1 ANTITRYPSIN GLYCOPROTEIN FOR USE IN TREATING NON-VIRAL INFLAMMATORY DISEASES OF THE LUNG | AATEC Medical GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4731249-A1 | A RECOMBINANT HUMAN ALPHA-1 ANTITRYPSIN GLYCOPROTEIN | AATEC Medical GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4731251-A1 | RECOMBINANT AAT FROM YEAST TO TREAT BACTERIAL RESPIRATORY INFECTIONS | AATEC Medical GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20230055572-A1 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | VENN BIOSCIENCES CORPORATION (US) | 2023-02-23 | — | — | US | disclosed |
| US-20230048743-A1 | Structures for Reducing Antibody-Lipase Binding | GENENTECH INC. (US) | 2023-02-16 | — | — | US | disclosed |
| US-11453901-B2 | Cell-free glycoprotein synthesis (CFGpS) in prokaryotic cell lysates enriched with components for glycosylation | NORTHWESTERN UNIVERSITY (US) | 2022-09-27 | — | — | US | disclosed |
| US-20220290165-A1 | PROTEASE DEFICIENT FILAMENTOUS FUNGAL CELLS AND METHODS OF USE THEREOF | GLYKOS FINLAND OY (FI) | 2022-09-15 | — | — | US | disclosed |
| CN-107375919-B | Methods and compositions for antiviral immunization | 台湾地区“中央研究院” | 2022-07-29 | — | — | CN | disclosed |
| US-20220139499-A1 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | VENN BIOSCIENCES CORPORATION | 2022-05-05 | — | — | US | disclosed |